Procoagulant activity in patients with sickle cell trait

Blood Coagulation and Fibrinolysis

Volumn 23, Issue 4, 2012, Pages 268-270

  Lawrie, Andrew S ^a   Pizzey, Arnold ^a   Trompeter, Sara ^a   Meiselman, Herbert ^b   Mohandas, Narla ^c   Dumanski, Jan P ^d   Westerman, Maxwell P ^e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NEW YORK BLOOD CENTER   (United States)

^d UPPSALA UNIVERSITY   (Sweden)

^e Medical Center   (United States)

Author keywords

endogenous thrombin potential; microparticles; prothrombotic; sickle cell trait; thrombin generation

Indexed keywords

ANTITHROMBIN; D DIMER; PROCOAGULANT; THROMBIN;

ADULT; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CELL AGGREGATION; CLINICAL ASSESSMENT; ERYTHROCYTE; ERYTHROCYTE DEFORMABILITY; EX VIVO STUDY; FIBRINOLYSIS; FLOW CYTOMETRY; HUMAN; HYPERCOAGULABILITY; IN VIVO STUDY; MEMBRANE MICROPARTICLE; MONOZYGOTIC TWINS; PRIORITY JOURNAL; RISK FACTOR; SICKLE CELL TRAIT; THROMBIN TIME; THROMBOSIS;

ANTITHROMBIN III; BLOOD COAGULATION TESTS; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MIDDLE AGED; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; PROTHROMBIN; RISK FACTORS; SICKLE CELL TRAIT; THROMBOPHILIA; THROMBOSIS; TWINS;

EID: 84861094506     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32835187f8     Document Type: Article

References (18)

1. Westerman MP, Green D, Gilman-Sachs A, Beaman K, Freels S, Boggio L, et al. Coagulation changes in individuals with sickle cell trait. Am J Hematol 2002;69:89-94.
2. Adam SS, Zaher G, Ibrahim M, Ataga KI, De Castro LM, Key NS. Markers of coagulation activation and inflammation in sickle cell disease and sickle cell trait. Blood 2008;112:4813; Abstract.
3. Austin H, Key NS, Benson JM, Lally C, Dowling NF, Whitsett C, Hooper WC. Sickle cell trait and the risk of venous thromboembolism among blacks. Blood 2007;110:908-912.
4. Eichner ER. Sickle cell trait. J Sport Rehabil 2007;16:197-203.
5. Kark JA, Posey DM, Schumacher HR, Ruehle CJ. Sickle-cell trait as a risk factor for sudden death in physical training. N Engl J Med 1987;317:781-787.
6. Westerman M, Pizzey A, Hirschman J, Cerino M, Weil-Weiner Y, Ramotar P, et al. Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy. Br J Haematol 2008;142:126-135.
7. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2000;284:3043-3045.
8. Razzaghian HR, Shahi MH, Forsberg LA, de Stahl TD, Absher D, Dahl N, et al. Somatic mosaicism for chromosome X and Y aneuploidies in monozygotic twins heterozygous for sickle cell disease mutation. Am J Med Genet A 2010;152A:2595-2598.
9. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003;33:4-15.
10. Mohandas N, Clark MR, Jacobs MS, Shohet SB. Analysis of factors regulating erythrocyte deformability. J Clin Invest 1980;66:563-573.
11. Hardeman MR, Goedhart PT, Shin S. Methods in hemorheology. In: Baskurt OK, Hardeman MR, Rampling MW, Meiselman HJ, editors. Handbook of Hemorheology and Hemodynamics. Amsterdam: IOS Press; 2007. pp. 242-266.
12. Luddington R, Baglin T. Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. J Thromb Haemost 2004;2:1954-1959.
13. Baglin T. Unraveling the thrombophilia paradox: from hypercoagulability to the prothrombotic. J Thromb Haemost 2010;8:228-233.
14. Westerman MP, Cole ER, Wu K. The effect of spicules obtained from sickle red cells on clotting activity. Br J Haematol 1984;56:557-562.
15. Franck PF, Bevers EM, Lubin BH, Comfurius P, Chiu DT, Op den Kamp JA, et al. Uncoupling of the membrane skeleton from the lipid bilayer. The cau1se of accelerated phospholipid flip-flop leading to an enhanced procoagulant activity of sickled cells. J Clin Invest 1985;75:183-190.
16. van Beers EJ, Schaap MC, Berckmans RJ, Nieuwland R, Sturk A, van Doormaal FF, et al. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica 2009;94:1513-1519.
17. Warren JD, Blumbergs PC, Thompson PD. Rhabdomyolysis: a review. Muscle Nerve 2002;25:332-347.
18. Huerta-Alardin AL, Varon J, Marik PE. Bench-to-bedside review: rhabdomyolysis - an overview for clinicians. Crit Care 2005;9:158-169.